Antitumour uridine analogues

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19/06 (2006.01) A61K 31/7064 (2006.01) A61P 35/00 (2006.01) C07H 19/04 (2006.01) C12Q 1/18 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2307002

Methods of diagnosing and/or of treating tu-mors by administering a nucleoside analogue which is activated by thymidylate synthase and/or thymi-dine kinase enzyme into a diagnostic or toxic metabolite, and uridine analogue compounds, and compositions of same having a pharmaceutically ac-ceptable carrier. For diagnostic applications, com-pounds containing a label and methods of use of such compounds are described.

La présente invention concerne des procédés de diagnostic et/ou de traitement de tumeurs constant à administrer un analogue de nucléoside activé par une enzyme de thymidylate synthase et/ou de thymidine kinase dans un métabolite diagnostique ou toxique, des composés analogues d'uridine, et des compositions de ceux-ci possédant un transporteur pharmaceutiquement acceptable. La présente invention concerne également des composés pour des applications diagnostiques contenant un marqueur et des procédés d'utilisation de ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antitumour uridine analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumour uridine analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumour uridine analogues will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1519512

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.